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Abstract 
Post-therapy preventive and therapeutic strategies for dental management are essential. Usually most of the 
dental procedures that were postponed before and during oncologic therapy can be performed post therapy. This 
post-cancer therapy multidisciplinary oral management is directed at minimizing recurrence of disease, 
providing palliation, and improving the quality of life of patients. Hence, this paper provides a pathway of 
multidisciplinary oral management following cancer therapy.    
Keywords: Continuous therapy; osteoradionecrosis; xerostomia. 
1. Introduction  
Patients with head and neck cancers often suffer from acute and late reactions to cancer therapy. Severity of oral 
complications may be based on the extent of tumor, as well as the type and extent of therapy. Some 
complications are transient, whereas others require a long term management as a result of permanent 
dysfunction. These patients are usually at high risk of recurrence or secondary malignancies, and therefore 
require close long term follow up.  
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Hence under these case scenario pathway of management encompasses continuous therapy phase, with aim to 
ensure continuing oral care, monitor oral condition of children especially, during their period of growth and 
development, and reassessment therapy phase, with aim to review oral conditions and period of follow up which 
should be at least be equivalent to the period of assessment of cancer by the Oncology team. These monitoring 
should be focused on stabilization/elimination of etiological factors, diet analysis and counselling to control or 
reduce the effect of aetiological factors, prescription of neutral, sodium fluoride mouth rinses or gel for daily 
use, thorough oral prophylaxis, consultation with oncologic team for further referral, if required. 
 
Figure1: Oral Management of Patient after Cancer Therapy. 
2. Oral Management after cancer therapy 
2.1. Prevention and Monitoring  
• There should be at least every six months oral health review in general and a three month review is 
recommended for patients with xerostomia, trismus, severe mucositis.  
• Regular and appropriate oral health care monitoring should include regular radiographs, oral health advice 
and preventive regime reinforcement.  
• Strategies for handling xerostomia, fluoride supplements appropriate to age should continue. Chlorhexidine 
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gel can be applied with applicators every three months. In case of trismus, jaw exercises are implemented. 
2.2. General Considerations  
• Patients on maintenance chemotherapy should have a complete blood picture be performed within the 24-48 
hour period prior to any proposed dental treatment that might result in bleeding/bacteraemia.  
• Herpes labialis can be a major chronic problem. Topical acyclovir (5% cream applied five times daily for 
five to ten days, starting at first sign of attack) is effective [1]. 
• Following radiation therapy progressive jaw stiffness and limited mouth opening occurred. Various mouth 
exercises are advisable to minimize the problem. A wedge made by taping together tongue spatulas can be 
used as aid which can act both as a guide to improved opening and as a target at least 3-4 times daily. [2]. 
Trigger point injections, analgesics and muscle relaxants can also be used.   
2.3. Orthodontic Considerations [3]  
• Orthodontic treatment can start once the patient has been free of cancer for one year.  
• Any developmental disturbances, extensive root damage/lack of root development that may have occurred 
due to their medical treatment must be assessed to decide on their suitability for orthodontics.  
2.4. Periodontal Considerations 
• Irradiated patients are at increased risk of progressive, uncontrolled periodontal disease and/or 
osteoradionecrosis [4,5]. 
• In the few instances of chemotherapy induced gingival hyperplasia, oral hygiene instructions, supra- and 
subgingival scaling, and gingival curettage should be carried out. This has been found to reduce the need 
for gingivectomy [6].  
2.5. Restorative and Prosthetic Considerations  
• Reconstructive prostheses should be simple in design, functional and provide acceptable aesthetics.  
• It is recommended that the complete or partial denture should be avoided wherever possible in case patient 
demonstrated poor oral hygiene practice. When patient maintaining oral hygiene, dentures are essential to 
restore function and, by extrapolation, promote social adaptation and weight gain [7]. 
• Post radiation xerostomic patients showed cervical caries as a major problem. Conservative restorative 
management is recommended initially and if patient demonstrated good oral hygiene only then, full/partial 
coverage crowns should be considered.  Fluoride releasing restorative materials such as conventional glass 
ionomer restorations has been found to perform more poorly that amalgam restorations resin modified glass 
ionomer and composite resin in patients who have been treated with radiotherapy. Edentulous patients, 
artificial saliva reservoir can be provided within the prosthesis; this may help to alleviate xerostomia 
temporarily [8].  
• In the event of oral candida infection, antifungal therapy should be prescribed for at least two consecutive 
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weeks [9,10]. In case of denture wearing patient miconazole varnish or gel can be applied to fit denture 
surface. Nystatin powder- 500,000-1000000 units per application of Viscogel can be incorporated into a 
denture soft lining material. These modified relining materials require to be changed on a regular basis i.e. 
between seven and fourteen days [11-15]. Tea tree oil (M. Alternifolia) has an antifungal activity and can be 
mixed with the Coe Comfort tissue conditioner and could be used as an alternative therapy for denture 
stomatitis which is resistant to other therapies [16]. Microwave disinfection of maxillary complete dentures 
has also been found to be effective [17,18].  If these therapies appear ineffective, prosthesis wear should be 
discontinued. New dentures may be required to alleviate symptoms.  
• Interim obturator should be reviewed regularly. They may require frequent adjustment. Definitive obturator 
should be considered only after four to six months when healing phase completed.  
• Osseointegrated implants can be a useful adjunct to fixed or removable prosthesis with provision to 
improve prosthesis stability. Regarding zygomatic implants, there is limited high quality evidence available 
at present [18,19]. There is limited evidence available regarding the use of HBOT prior to implant 
placement in irradiated patients.  Hyperbaric oxygen therapy may not offer any appreciable clinical benefits 
with respect to implant success. The placement of implants in patients who are being treated with 
bisphosphonates is not recommended with implant placement increasing the damage to the bony structures 
and increasing the risk of osteonecrosis. 
2.6. Consideration for Osteoradionecrosis 
• A recent systematic review has estimated 7 % of total incidence of osteoradionecrosis after tooth extraction 
in irradiated patients. However, only 4% of total incidence of osteoradionecrosis in conjunction with 
prophylactic hyperbaric oxygen therapy (HBOT) and 6% of total incidence in conjunction with antibiotics 
were noticed [19]. Patients who have received bisphosphonate therapy are also at increased risk of 
osteonecrosis.  
• Before proceeding for any dental treatment establish the diagnosis of osteoradionecrosis and staging is 
must, ensuring that the bony changes are not due to malignancy.  Following diagnosis of osteoradionecrosis 
it is recommended that oral trauma should be minimized by instigating soft diet plan, adjusting of denture 
contributing to trauma. Extractions are to be avoided where possible, particularly in the mandible. Local 
measures should be employed to relieve symptoms including topical/systemic analgesia. In most chronic 
cases the presence of Actinomycoses must be considered. The antibiotic of choice should be broad 
spectrum, sequestrectomy should be given and continued until mucosal integrity has occurred [18,19]. 
Localised surgical excision of exposed necrosed bone with primary mucosal closure may become 
necessary.  At high risk of osteoradionecrosis, consideration to root canal therapy and restoration/crown 
amputation is must [21]. It is recommended that antibiotic treatment is initiated prior to Hyperbaric Oxygen 
Therapy and continued through the surgical phase and post-surgery [22-24]. However, there is an increased 
risk of tumour recurrence in patients who receive hyperbaric oxygen therapy [25-27]. There have been 
promising results with ultrasound at frequencies of 3mHz pulsed one in four at an intensity of 1W/cm2 
applied to the mandible for ten minutes daily for fifty days [28,29]. Hence, osteoradionecrosis can be 
avoided by careful oral health monitoring and ensuring prevention compliance, timely dental treatment and 
dealing promptly with oral trauma. 
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3. Conclusion 
The outlook, before, during and after treatment, for malignant disease, has significantly improved in the last few 
decades. Appropriate preventive regimens and timely oral care can minimize complications and improve quality 
of life. The patient‘s oral care and function is an important contributor to post-treatment social adaptation and 
life quality. 
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